FDA authorization supports a mid-stage clinical evaluation of CK0802 in steroid-refractory GVHD, where steroid nonresponse is ...

Hello, everyone, and welcome to GBDC's earnings call for the fiscal quarter ended March 31, 2026. Before we begin, I'd like to take a moment to remind our listeners that remarks made during this call ...

Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...

In most of the world, and particularly across Southeast Asia, the answer is not yet. Here, we focus on what those choices ...

Aviat Networks’ role in wireless transport solutions, enterprise connectivity, and market trends shaping communications ...

Operator: Thank you for standing by, and welcome to Corcept Therapeutics First Quarter 2026 Earnings Conference Call.

For the more than 50 million Americans living with chronic pain, the question has always been the same: why does it stay? A ...

Ukrainian warfighters explain how defense companies can succeed—and what developments and investment is actually needed on ...

This project provides a simple and practical solution using an Interactive Voice Response System (IVRS) that works completely ...

Total Revenue -- $164.9 million, up from $157.2 million the previous year; reflects increasing prescriptions and patient volume. Prescription Trends -- Record levels of new prescriptions, new patient ...

A light brush of fabric against skin should not cause agony. But for the roughly 51 million American adults living with ...

Mediterranean diet is good for you, but most people picture it as little more than olive oil, and salads. The reality is far ...